Gene Therapy Development for Glaucoma
Posted 2024-04-11 07:56:51
0
885

Glaucoma is a complex disease, and currently the only way to maintain patient health is by lowering intraocular pressure. Gene therapy to treat the disease is rapidly evolving. This is a much needed area of glaucoma treatment that can be applied to a variety of glaucoma types.
A major risk factor for glaucoma is high IOP and causes blindness primarily due to RGC damage and death. Therefore, Ace Ophthalmology provides gene therapy development services for glaucoma, targeting candidate genes related to IOP and RGC, as well as many other related genes and pathways.
Learn more:glaucoma gene delivery system development service
Zoeken
Categorieën
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Spellen
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Other
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness
- IT, Cloud, Software and Technology
Read More
Antiandrogens Market Demand, Size, Share, Growth Opportunities, Market Potential, Segmentation, Trends & Global Industry Forecast to 2032
The Antiandrogens Market is expected to reach USD 9.5 Billion by 2032 at 7.1% CAGR during the...
Tout Savoir sur l'Achat de FIFA Coins FC 25 et le Crédit FIFA 25
Tout Savoir sur l'Achat de FIFA Coins FC 25 et le Crédit FIFA 25
Dans l'univers...
Narrowband IoT (NB-IoT) Market Unleashing the full potential 2030
The global narrowband Internet of Things (NB-IoT) market size is expected...
Arc Welding Equipment: Crafting Stronger Connections Every Day
The global arc welding equipment market is experiencing steady growth, driven by...
Future Prospects of the Photocatalytic Coating Market
The Photocatalytic Coating Market is estimated to be valued at US$ 3.41 Bn in 2023 and is...